img

Global Rifaximin API Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Rifaximin API Market Insights, Forecast to 2034

Global Rifaximin API market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Rifaximin API industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Rifaximin API key manufacturers include Salix Pharmaceuticals, Lupin, LGM Pharma, B Joshi Agrochem Pharma and Triveni Interchem, etc. Salix Pharmaceuticals, Lupin, LGM Pharma are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Rifaximin API were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Rifaximin API market and estimated to attract more attentions from industry insiders and investors.
Rifaximin API can be divided into 99% Purity and >99% Purity, etc. 99% Purity is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Rifaximin API is widely used in various fields, such as Pharmaceuticals and Others, etc. Pharmaceuticals provides greatest supports to the Rifaximin API industry development. In 2022, global % sales of Rifaximin API went into Pharmaceuticals filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Rifaximin API market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Rifaximin API market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Salix Pharmaceuticals
Lupin
LGM Pharma
B Joshi Agrochem Pharma
Triveni Interchem
Segment by Type
99% Purity
>99% Purity

Segment by Application


Pharmaceuticals
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Rifaximin API plant distribution, commercial date of Rifaximin API, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Rifaximin API introduction, etc. Rifaximin API Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Rifaximin API
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Rifaximin API Product Introduction
1.2 Market by Type
1.2.1 Global Rifaximin API Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 99% Purity
1.2.3 >99% Purity
1.3 Market by Application
1.3.1 Global Rifaximin API Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Pharmaceuticals
1.3.3 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Rifaximin API Sales Estimates and Forecasts 2018-2029
2.2 Global Rifaximin API Revenue by Region
2.2.1 Global Rifaximin API Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Rifaximin API Revenue by Region (2018-2024)
2.2.3 Global Rifaximin API Revenue by Region (2024-2029)
2.2.4 Global Rifaximin API Revenue Market Share by Region (2018-2029)
2.3 Global Rifaximin API Sales Estimates and Forecasts 2018-2029
2.4 Global Rifaximin API Sales by Region
2.4.1 Global Rifaximin API Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Rifaximin API Sales by Region (2018-2024)
2.4.3 Global Rifaximin API Sales by Region (2024-2029)
2.4.4 Global Rifaximin API Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Rifaximin API Sales by Manufacturers
3.1.1 Global Rifaximin API Sales by Manufacturers (2018-2024)
3.1.2 Global Rifaximin API Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rifaximin API in 2022
3.2 Global Rifaximin API Revenue by Manufacturers
3.2.1 Global Rifaximin API Revenue by Manufacturers (2018-2024)
3.2.2 Global Rifaximin API Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Rifaximin API Revenue in 2022
3.3 Global Key Players of Rifaximin API, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Rifaximin API Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Rifaximin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Rifaximin API, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Rifaximin API, Product Offered and Application
3.8 Global Key Manufacturers of Rifaximin API, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rifaximin API Sales by Type
4.1.1 Global Rifaximin API Historical Sales by Type (2018-2024)
4.1.2 Global Rifaximin API Forecasted Sales by Type (2024-2029)
4.1.3 Global Rifaximin API Sales Market Share by Type (2018-2029)
4.2 Global Rifaximin API Revenue by Type
4.2.1 Global Rifaximin API Historical Revenue by Type (2018-2024)
4.2.2 Global Rifaximin API Forecasted Revenue by Type (2024-2029)
4.2.3 Global Rifaximin API Revenue Market Share by Type (2018-2029)
4.3 Global Rifaximin API Price by Type
4.3.1 Global Rifaximin API Price by Type (2018-2024)
4.3.2 Global Rifaximin API Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Rifaximin API Sales by Application
5.1.1 Global Rifaximin API Historical Sales by Application (2018-2024)
5.1.2 Global Rifaximin API Forecasted Sales by Application (2024-2029)
5.1.3 Global Rifaximin API Sales Market Share by Application (2018-2029)
5.2 Global Rifaximin API Revenue by Application
5.2.1 Global Rifaximin API Historical Revenue by Application (2018-2024)
5.2.2 Global Rifaximin API Forecasted Revenue by Application (2024-2029)
5.2.3 Global Rifaximin API Revenue Market Share by Application (2018-2029)
5.3 Global Rifaximin API Price by Application
5.3.1 Global Rifaximin API Price by Application (2018-2024)
5.3.2 Global Rifaximin API Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Rifaximin API Market Size by Type
6.1.1 US & Canada Rifaximin API Sales by Type (2018-2029)
6.1.2 US & Canada Rifaximin API Revenue by Type (2018-2029)
6.2 US & Canada Rifaximin API Market Size by Application
6.2.1 US & Canada Rifaximin API Sales by Application (2018-2029)
6.2.2 US & Canada Rifaximin API Revenue by Application (2018-2029)
6.3 US & Canada Rifaximin API Market Size by Country
6.3.1 US & Canada Rifaximin API Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Rifaximin API Sales by Country (2018-2029)
6.3.3 US & Canada Rifaximin API Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Rifaximin API Market Size by Type
7.1.1 Europe Rifaximin API Sales by Type (2018-2029)
7.1.2 Europe Rifaximin API Revenue by Type (2018-2029)
7.2 Europe Rifaximin API Market Size by Application
7.2.1 Europe Rifaximin API Sales by Application (2018-2029)
7.2.2 Europe Rifaximin API Revenue by Application (2018-2029)
7.3 Europe Rifaximin API Market Size by Country
7.3.1 Europe Rifaximin API Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Rifaximin API Sales by Country (2018-2029)
7.3.3 Europe Rifaximin API Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Rifaximin API Market Size
8.1.1 China Rifaximin API Sales (2018-2029)
8.1.2 China Rifaximin API Revenue (2018-2029)
8.2 China Rifaximin API Market Size by Application
8.2.1 China Rifaximin API Sales by Application (2018-2029)
8.2.2 China Rifaximin API Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Rifaximin API Market Size by Type
9.1.1 Asia Rifaximin API Sales by Type (2018-2029)
9.1.2 Asia Rifaximin API Revenue by Type (2018-2029)
9.2 Asia Rifaximin API Market Size by Application
9.2.1 Asia Rifaximin API Sales by Application (2018-2029)
9.2.2 Asia Rifaximin API Revenue by Application (2018-2029)
9.3 Asia Rifaximin API Sales by Region
9.3.1 Asia Rifaximin API Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Rifaximin API Revenue by Region (2018-2029)
9.3.3 Asia Rifaximin API Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Rifaximin API Market Size by Type
10.1.1 Middle East, Africa and Latin America Rifaximin API Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Rifaximin API Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Rifaximin API Market Size by Application
10.2.1 Middle East, Africa and Latin America Rifaximin API Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Rifaximin API Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Rifaximin API Sales by Country
10.3.1 Middle East, Africa and Latin America Rifaximin API Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Rifaximin API Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Rifaximin API Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Salix Pharmaceuticals
11.1.1 Salix Pharmaceuticals Company Information
11.1.2 Salix Pharmaceuticals Overview
11.1.3 Salix Pharmaceuticals Rifaximin API Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Salix Pharmaceuticals Rifaximin API Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Salix Pharmaceuticals Recent Developments
11.2 Lupin
11.2.1 Lupin Company Information
11.2.2 Lupin Overview
11.2.3 Lupin Rifaximin API Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Lupin Rifaximin API Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Lupin Recent Developments
11.3 LGM Pharma
11.3.1 LGM Pharma Company Information
11.3.2 LGM Pharma Overview
11.3.3 LGM Pharma Rifaximin API Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 LGM Pharma Rifaximin API Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 LGM Pharma Recent Developments
11.4 B Joshi Agrochem Pharma
11.4.1 B Joshi Agrochem Pharma Company Information
11.4.2 B Joshi Agrochem Pharma Overview
11.4.3 B Joshi Agrochem Pharma Rifaximin API Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 B Joshi Agrochem Pharma Rifaximin API Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 B Joshi Agrochem Pharma Recent Developments
11.5 Triveni Interchem
11.5.1 Triveni Interchem Company Information
11.5.2 Triveni Interchem Overview
11.5.3 Triveni Interchem Rifaximin API Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Triveni Interchem Rifaximin API Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Triveni Interchem Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Rifaximin API Industry Chain Analysis
12.2 Rifaximin API Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rifaximin API Production Mode & Process
12.4 Rifaximin API Sales and Marketing
12.4.1 Rifaximin API Sales Channels
12.4.2 Rifaximin API Distributors
12.5 Rifaximin API Customers
13 Market Dynamics
13.1 Rifaximin API Industry Trends
13.2 Rifaximin API Market Drivers
13.3 Rifaximin API Market Challenges
13.4 Rifaximin API Market Restraints
14 Key Findings in The Global Rifaximin API Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Rifaximin API Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 99% Purity
Table 3. Major Manufacturers of >99% Purity
Table 4. Global Rifaximin API Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Rifaximin API Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Rifaximin API Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Rifaximin API Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Rifaximin API Revenue Market Share by Region (2018-2024)
Table 9. Global Rifaximin API Revenue Market Share by Region (2024-2029)
Table 10. Global Rifaximin API Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Rifaximin API Sales by Region (2018-2024) & (Kiloton)
Table 12. Global Rifaximin API Sales by Region (2024-2029) & (Kiloton)
Table 13. Global Rifaximin API Sales Market Share by Region (2018-2024)
Table 14. Global Rifaximin API Sales Market Share by Region (2024-2029)
Table 15. Global Rifaximin API Sales by Manufacturers (2018-2024) & (Kiloton)
Table 16. Global Rifaximin API Sales Share by Manufacturers (2018-2024)
Table 17. Global Rifaximin API Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Rifaximin API Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Rifaximin API, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Rifaximin API Price by Manufacturers 2018-2024 (US$/Ton)
Table 21. Global Rifaximin API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Rifaximin API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rifaximin API as of 2022)
Table 23. Global Key Manufacturers of Rifaximin API, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Rifaximin API, Product Offered and Application
Table 25. Global Key Manufacturers of Rifaximin API, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Rifaximin API Sales by Type (2018-2024) & (Kiloton)
Table 28. Global Rifaximin API Sales by Type (2024-2029) & (Kiloton)
Table 29. Global Rifaximin API Sales Share by Type (2018-2024)
Table 30. Global Rifaximin API Sales Share by Type (2024-2029)
Table 31. Global Rifaximin API Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Rifaximin API Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Rifaximin API Revenue Share by Type (2018-2024)
Table 34. Global Rifaximin API Revenue Share by Type (2024-2029)
Table 35. Rifaximin API Price by Type (2018-2024) & (US$/Ton)
Table 36. Global Rifaximin API Price Forecast by Type (2024-2029) & (US$/Ton)
Table 37. Global Rifaximin API Sales by Application (2018-2024) & (Kiloton)
Table 38. Global Rifaximin API Sales by Application (2024-2029) & (Kiloton)
Table 39. Global Rifaximin API Sales Share by Application (2018-2024)
Table 40. Global Rifaximin API Sales Share by Application (2024-2029)
Table 41. Global Rifaximin API Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Rifaximin API Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Rifaximin API Revenue Share by Application (2018-2024)
Table 44. Global Rifaximin API Revenue Share by Application (2024-2029)
Table 45. Rifaximin API Price by Application (2018-2024) & (US$/Ton)
Table 46. Global Rifaximin API Price Forecast by Application (2024-2029) & (US$/Ton)
Table 47. US & Canada Rifaximin API Sales by Type (2018-2024) & (Kiloton)
Table 48. US & Canada Rifaximin API Sales by Type (2024-2029) & (Kiloton)
Table 49. US & Canada Rifaximin API Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Rifaximin API Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Rifaximin API Sales by Application (2018-2024) & (Kiloton)
Table 52. US & Canada Rifaximin API Sales by Application (2024-2029) & (Kiloton)
Table 53. US & Canada Rifaximin API Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Rifaximin API Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Rifaximin API Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Rifaximin API Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Rifaximin API Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Rifaximin API Sales by Country (2018-2024) & (Kiloton)
Table 59. US & Canada Rifaximin API Sales by Country (2024-2029) & (Kiloton)
Table 60. Europe Rifaximin API Sales by Type (2018-2024) & (Kiloton)
Table 61. Europe Rifaximin API Sales by Type (2024-2029) & (Kiloton)
Table 62. Europe Rifaximin API Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Rifaximin API Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Rifaximin API Sales by Application (2018-2024) & (Kiloton)
Table 65. Europe Rifaximin API Sales by Application (2024-2029) & (Kiloton)
Table 66. Europe Rifaximin API Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Rifaximin API Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Rifaximin API Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Rifaximin API Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Rifaximin API Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Rifaximin API Sales by Country (2018-2024) & (Kiloton)
Table 72. Europe Rifaximin API Sales by Country (2024-2029) & (Kiloton)
Table 73. China Rifaximin API Sales by Type (2018-2024) & (Kiloton)
Table 74. China Rifaximin API Sales by Type (2024-2029) & (Kiloton)
Table 75. China Rifaximin API Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Rifaximin API Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Rifaximin API Sales by Application (2018-2024) & (Kiloton)
Table 78. China Rifaximin API Sales by Application (2024-2029) & (Kiloton)
Table 79. China Rifaximin API Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Rifaximin API Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Rifaximin API Sales by Type (2018-2024) & (Kiloton)
Table 82. Asia Rifaximin API Sales by Type (2024-2029) & (Kiloton)
Table 83. Asia Rifaximin API Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Rifaximin API Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Rifaximin API Sales by Application (2018-2024) & (Kiloton)
Table 86. Asia Rifaximin API Sales by Application (2024-2029) & (Kiloton)
Table 87. Asia Rifaximin API Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Rifaximin API Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Rifaximin API Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Rifaximin API Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Rifaximin API Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Rifaximin API Sales by Region (2018-2024) & (Kiloton)
Table 93. Asia Rifaximin API Sales by Region (2024-2029) & (Kiloton)
Table 94. Middle East, Africa and Latin America Rifaximin API Sales by Type (2018-2024) & (Kiloton)
Table 95. Middle East, Africa and Latin America Rifaximin API Sales by Type (2024-2029) & (Kiloton)
Table 96. Middle East, Africa and Latin America Rifaximin API Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Rifaximin API Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Rifaximin API Sales by Application (2018-2024) & (Kiloton)
Table 99. Middle East, Africa and Latin America Rifaximin API Sales by Application (2024-2029) & (Kiloton)
Table 100. Middle East, Africa and Latin America Rifaximin API Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Rifaximin API Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Rifaximin API Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Rifaximin API Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Rifaximin API Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Rifaximin API Sales by Country (2018-2024) & (Kiloton)
Table 106. Middle East, Africa and Latin America Rifaximin API Sales by Country (2024-2029) & (Kiloton)
Table 107. Salix Pharmaceuticals Company Information
Table 108. Salix Pharmaceuticals Description and Major Businesses
Table 109. Salix Pharmaceuticals Rifaximin API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 110. Salix Pharmaceuticals Rifaximin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Salix Pharmaceuticals Recent Developments
Table 112. Lupin Company Information
Table 113. Lupin Description and Major Businesses
Table 114. Lupin Rifaximin API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 115. Lupin Rifaximin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Lupin Recent Developments
Table 117. LGM Pharma Company Information
Table 118. LGM Pharma Description and Major Businesses
Table 119. LGM Pharma Rifaximin API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 120. LGM Pharma Rifaximin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. LGM Pharma Recent Developments
Table 122. B Joshi Agrochem Pharma Company Information
Table 123. B Joshi Agrochem Pharma Description and Major Businesses
Table 124. B Joshi Agrochem Pharma Rifaximin API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 125. B Joshi Agrochem Pharma Rifaximin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. B Joshi Agrochem Pharma Recent Developments
Table 127. Triveni Interchem Company Information
Table 128. Triveni Interchem Description and Major Businesses
Table 129. Triveni Interchem Rifaximin API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 130. Triveni Interchem Rifaximin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Triveni Interchem Recent Developments
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Rifaximin API Distributors List
Table 135. Rifaximin API Customers List
Table 136. Rifaximin API Market Trends
Table 137. Rifaximin API Market Drivers
Table 138. Rifaximin API Market Challenges
Table 139. Rifaximin API Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Rifaximin API Product Picture
Figure 2. Global Rifaximin API Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Rifaximin API Market Share by Type in 2022 & 2029
Figure 4. 99% Purity Product Picture
Figure 5. >99% Purity Product Picture
Figure 6. Global Rifaximin API Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Rifaximin API Market Share by Application in 2022 & 2029
Figure 8. Pharmaceuticals
Figure 9. Others
Figure 10. Rifaximin API Report Years Considered
Figure 11. Global Rifaximin API Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Rifaximin API Revenue 2018-2029 (US$ Million)
Figure 13. Global Rifaximin API Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Rifaximin API Revenue Market Share by Region (2018-2029)
Figure 15. Global Rifaximin API Sales 2018-2029 ((Kiloton)
Figure 16. Global Rifaximin API Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Rifaximin API Sales YoY (2018-2029) & (Kiloton)
Figure 18. US & Canada Rifaximin API Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Rifaximin API Sales YoY (2018-2029) & (Kiloton)
Figure 20. Europe Rifaximin API Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Rifaximin API Sales YoY (2018-2029) & (Kiloton)
Figure 22. China Rifaximin API Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Rifaximin API Sales YoY (2018-2029) & (Kiloton)
Figure 24. Asia (excluding China) Rifaximin API Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Rifaximin API Sales YoY (2018-2029) & (Kiloton)
Figure 26. Middle East, Africa and Latin America Rifaximin API Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Rifaximin API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Rifaximin API in the World: Market Share by Rifaximin API Revenue in 2022
Figure 29. Global Rifaximin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Rifaximin API Sales Market Share by Type (2018-2029)
Figure 31. Global Rifaximin API Revenue Market Share by Type (2018-2029)
Figure 32. Global Rifaximin API Sales Market Share by Application (2018-2029)
Figure 33. Global Rifaximin API Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Rifaximin API Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Rifaximin API Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Rifaximin API Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Rifaximin API Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Rifaximin API Revenue Share by Country (2018-2029)
Figure 39. US & Canada Rifaximin API Sales Share by Country (2018-2029)
Figure 40. U.S. Rifaximin API Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Rifaximin API Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Rifaximin API Sales Market Share by Type (2018-2029)
Figure 43. Europe Rifaximin API Revenue Market Share by Type (2018-2029)
Figure 44. Europe Rifaximin API Sales Market Share by Application (2018-2029)
Figure 45. Europe Rifaximin API Revenue Market Share by Application (2018-2029)
Figure 46. Europe Rifaximin API Revenue Share by Country (2018-2029)
Figure 47. Europe Rifaximin API Sales Share by Country (2018-2029)
Figure 48. Germany Rifaximin API Revenue (2018-2029) & (US$ Million)
Figure 49. France Rifaximin API Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Rifaximin API Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Rifaximin API Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Rifaximin API Revenue (2018-2029) & (US$ Million)
Figure 53. China Rifaximin API Sales Market Share by Type (2018-2029)
Figure 54. China Rifaximin API Revenue Market Share by Type (2018-2029)
Figure 55. China Rifaximin API Sales Market Share by Application (2018-2029)
Figure 56. China Rifaximin API Revenue Market Share by Application (2018-2029)
Figure 57. Asia Rifaximin API Sales Market Share by Type (2018-2029)
Figure 58. Asia Rifaximin API Revenue Market Share by Type (2018-2029)
Figure 59. Asia Rifaximin API Sales Market Share by Application (2018-2029)
Figure 60. Asia Rifaximin API Revenue Market Share by Application (2018-2029)
Figure 61. Asia Rifaximin API Revenue Share by Region (2018-2029)
Figure 62. Asia Rifaximin API Sales Share by Region (2018-2029)
Figure 63. Japan Rifaximin API Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Rifaximin API Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Rifaximin API Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Rifaximin API Revenue (2018-2029) & (US$ Million)
Figure 67. India Rifaximin API Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Rifaximin API Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Rifaximin API Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Rifaximin API Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Rifaximin API Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Rifaximin API Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Rifaximin API Sales Share by Country (2018-2029)
Figure 74. Brazil Rifaximin API Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Rifaximin API Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Rifaximin API Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Rifaximin API Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Rifaximin API Revenue (2018-2029) & (US$ Million)
Figure 79. Rifaximin API Value Chain
Figure 80. Rifaximin API Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries